ascopubs.org

Predictive value of PET-CT and tumor biology for pathological complete response in triple-negative breast cancer treated with neoadjuvant pembrolizumab: A real-world analysis.

Type 2 cytokines in breast epithelial homeostasis. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not include a full text component.
ascopubs.org

Predictive value of PIK3CA mutations for response to CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer: A systematic review and meta-analysis.

Trastuzumab deruxtecan (T-DXd) in HER2-positive advanced breast cancer (ABC) with active CNS metastases: Real world data. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...